Top 3 Companies Owned by Valeant (VRX)
Total sales for all Salix products in 2014, boosted by acquiring products from overtaken companies, were over $1 billion.
Valeant bought Bausch & Lomb from the firm in 2013 in a deal worth over $8 billion,
with at least half of the total cash paid earmarked to pay off Bausch & Lomb debt.
Salix Pharmaceuticals is an American specialty pharmaceuticals company, the largest
gastrointestinal specialty pharmaceutical company in the world as of 2015.
The emerging market segment’s primary operation is the sale of generic-branded pharmaceutical products, OTC products and medical devices.
Operations of the former include the sale of OTC products and of pharmaceutical products sold in the United States.
Since its founding in 1994, Valeant has gained some undesirable attention as a pharmaceutical powerhouse
that gains brands through acquiring smaller or failing companies, pushes these products through into its own supply stream, then considerably raises prices.
Part of the healthcare sector, Valeant Pharmaceuticals International Inc. (NYSE:
VRX), is a specialty pharmaceutical company, operating in multiple countries.